Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangzhou Ruitai Biotechnology is a specialized life sciences company headquartered in Guangzhou, China, focusing on the development and commercialization of gene editing technologies. The company provides a robust portfolio of CRISPR/Cas9-based tools, molecular biology reagents, and cell engineering services to support global research and drug discovery efforts. Ruitai Bio is particularly known for its expertise in creating custom cell lines and providing high-efficiency gene modification solutions. By bridging the gap between basic research and clinical application, the company plays a vital role in the advancement of cell and gene therapies. Its products are widely utilized in academic institutions, biotechnology firms, and pharmaceutical companies worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangzhou Ruitai Biotechnology.